An Act Requiring Health Insurance Coverage For Reconstructive Surgery Following Melanoma Surgery On The Face.
Summary
HB 5327 would amend Connecticut’s insurance statutes to require individual and group health insurance policies to cover reconstructive surgery after melanoma surgery on the face. The required coverage would include procedures needed to correct disfigurement, restore normal facial symmetry, and address functional impairments resulting from the melanoma surgery.
The bill is narrowly focused on post-melanoma facial reconstruction rather than cancer treatment itself. It would place this type of reconstructive care within the scope of mandated health insurance benefits, ensuring that insured patients have coverage for medically necessary follow-up procedures after facial melanoma removal.
Impact
If enacted, the bill would change chapter 700c of the general statutes by adding a new coverage mandate for health insurers offering individual and group policies. Insurers would be required to pay for reconstructive procedures tied to facial melanoma surgery when those procedures are needed to repair disfigurement, restore symmetry, or correct functional problems. The practical effect would be to expand covered benefits for affected patients and impose additional coverage obligations on health plans operating in the state.
Sentiment
There is no recorded committee transcript or vote history for this bill in the provided materials, so no formal debate or roll-call sentiment is available. Based on the bill text alone, the proposal appears to be a targeted patient-protection measure aimed at ensuring access to medically necessary reconstructive care after cancer surgery. The framing suggests a generally supportive consumer- and patient-oriented purpose, but the available record does not show whether it was controversial.
Contention
No specific points of contention are documented in the provided materials. Potential areas of debate, if the bill were discussed, would likely involve the cost impact on insurers, the scope of what qualifies as reconstructive versus cosmetic surgery, and how medical necessity would be determined for coverage. However, none of those issues are attributed to any legislator, committee member, or stakeholder in the available record.